Test Directory

Clear All
Test Code
1480
Test Name
Arterial Tortuosity Syndrome
CPT Codes
81479
Expected Turnaround Time
Typically 2 to 4 weeks from receipt of a sample in the laboratory. All cases involving ongoing pregnancies will be expedited.
Clinical Utility
Genetic analysis to provide a molecular diagnosis of this disorder. Recommended for individuals with a personal and/or family history of this disorder to ensure appropriate treatment and establish recurrence risk for family members.
Specimen and Container Info

Non-Prenatal Specimens

Preferred/Alternate

Specimen Type

Containers

Volume

Preferred Specimen Type

Whole Blood

Lavender Top (EDTA)

3 mL

Alternate Specimen Type

Genomic DNA

1.5 mL Tube

3 µg (at a concentration of at least 30 ng/µl), preferably in TE solution.

Alternate Specimen Type

Fibroblasts

T-25 Flasks

2 confluent T-25 flasks, filled to capacity

Alternate Specimen Type

Saliva (Whole blood is recommended for CNV)

DNA Self-Collection Kit or Oragene Saliva Collection Kit for Young Children

Follow kit instructions (www.dnagenotek.com)

Prenatal Specimens

Either specimen type below is acceptable.

Specimen Type

Containers

Volume

Cultured cells

T-25 Flasks

2 confluent T-25 flasks derived from amnio or CVS samples.

Genomic DNA

1.5 mL Tube

3 µg (at a concentration of at least 30 ng/µl), preferably in TE solution.

NOTE: For specimens from outside of North America, the preferred specimen type is Genomic DNA. HNL Genomics does not recommend shipping whole blood or cultured cells from any location other than the United States, Canada, or Mexico.
Transport Instructions
  • Transport at room temperature within 24 hours.
  • If the specimen cannot be transported to the lab within 24 hours, refrigerate for up to 72 hours.
  • Do not freeze or expose to extreme temperatures, refrigerate for up to 72 hours if cannot be transported to lab within 24 hours. 
Stability Requirements

Room Temperature

24 hours

Refrigerated

72 hours
Causes for Rejection
  • Improperly labeled specimen (minimum of two patient identifiers)
  • Inappropriate specimen type
  • Incomplete or incorrect test request form
  • Insufficient volume
  • Specimen has leaked in transit
  • Specimen without a test order
Methodology
Next Generation Sequencing and Copy Number Variation Analysis
Performing Location
Genomics - Snowdrift
Alternate Names
ATS
Description

Arterial tortuosity syndrome (ATS; MIM 208050) is an autosomal recessive disorder characterized by tortuosity, elongation, and aneuryms of major arteries and the aorta. Additional cardiovascular findings may include aberrant origin of aortic branches, aortic stenosis, pulmonary artery or pulmonary valve stenosis or stenosis of additional arteries, and vasomotor instability. Craniofacial findings include a long face with a beaked nose in most patients, hypertelorism, short downslanting palpebral fissures, malar hypoplasia, sagging cheeks, large ears, and an aged appearance. Less frequently patients may display a high arched palate and micrognathia. Most individuals have joint laxity. Skeletal findings can include a pectus deformity, arachnodactyly, scoliosis and, less frequently contractures. Many patients are reported to have either inguinal or diaphragmatic hernia. The skin may be thin, velvety, and hyperextensible. The differential diagnosis includes Loeys-Dietz syndrome and some types of Ehlers-Danlos syndrome. Arterial tortuosity syndrome is caused by mutations in the solute carrier family 2, member 10 gene (SLC2A10). This gene encodes the glucose transporter GLUT10.
Testing Schedule
Monday-Friday
Genes
SLC2A10
MIM
208050
Disease Group
Cardiovascular Disorders, Connective Tissue
The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. View the Terms.
© 2026 HNL Lab Medicine. All rights reserved.